Piper Jaffray Downgrades Hologic (HOLX) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
BTIG Downgrades Hologic (HOLX) to Neutral
July 16, 2015 7:34 AM EDTBTIG downgraded Hologic (NASDAQ: HOLX) from Buy to Neutral. Analyst Sean Lavin said strong results are priced in and he views valuation as full.
"Today, we are downgrading shares to Neutral due to valuation. Shares are at an all-time high, having... More
UPDATE: Evercore ISI Downgrades Hologic (HOLX) to Hold
July 13, 2015 6:41 AM EDT(Updated - July 13, 2015 7:41 AM EDT)
Evercore ISI downgraded Hologic (NASDAQ: HOLX) from Buy to Hold with a price target of $38.50 (from $37.50). Analyst Vijay Kumar thinks the stock is appropriately pricing in the optimism.
"While we do agree that HOLX is in the sweet spot of its 3D-Tomo adoption... More
CMS Endorses Combined Pap/HPV Testing, Piper Jaffray Notes (HOLX) (QGEN) (BDX)
July 10, 2015 8:09 AM EDTPiper Jaffray analyst William Quirk noted that the CMS will cover combined HPV and pap smear testing once every five years, with a screening interval above current pap guidelines (3 years). The news is viewed positive for Hologic (NASDAQ: HOLX), Qiagen (NASDAQ:... More
